Co-Administered Polymeric Nano-Antidotes for Improved Photo-Triggered Response in Glioblastoma
出版年份 2018 全文链接
标题
Co-Administered Polymeric Nano-Antidotes for Improved Photo-Triggered Response in Glioblastoma
作者
关键词
-
出版物
Pharmaceutics
Volume 10, Issue 4, Pages 226
出版商
MDPI AG
发表日期
2018-11-14
DOI
10.3390/pharmaceutics10040226
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
- (2018) Xin Cui et al. BIOMATERIALS
- Reduction of cancer cell viability by synergistic combination of photodynamic treatment with the inhibition of the Id protein family
- (2018) Cornelia Roschger et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer
- (2018) Bowen Qi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Biodegradable MoOx nanoparticles with efficient near-infrared photothermal and photodynamic synergetic cancer therapy at the second biological window
- (2018) Wenyan Yin et al. Nanoscale
- Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo
- (2018) Benjamin M Ellingson et al. NEURO-ONCOLOGY
- Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer
- (2018) Rahul Jadia et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
- (2018) Ke-Li Liao et al. OncoTargets and Therapy
- Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma
- (2018) Yuan-Chung Tsai et al. Theranostics
- Current Strategies for Brain Drug Delivery
- (2018) Xiaowei Dong Theranostics
- pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer
- (2018) Jian-Dong Yuan et al. Artificial Cells Nanomedicine and Biotechnology
- Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy
- (2018) Elif Ozdemir-Kaynak et al. Frontiers in Physiology
- Bevacizumab and Glioblastoma
- (2018) Michelle M. Kim et al. CANCER JOURNAL
- Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling
- (2018) Stefania Elena Navone et al. World Neurosurgery
- Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials
- (2018) Zhouqing Chen et al. Cancer Management and Research
- The role of Cediranib in ovarian cancer
- (2017) Cecilia Orbegoso et al. EXPERT OPINION ON PHARMACOTHERAPY
- Combination of nanotechnology with vascular targeting agents for effective cancer therapy
- (2017) Rana Jahanban-Esfahlan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2
- (2017) Ming Lin et al. JOURNAL OF NEURO-ONCOLOGY
- Efficient cell death induction in human glioblastoma cells by photodynamic treatment with Tetrahydroporphyrin-Tetratosylat (THPTS) and ionizing irradiation
- (2017) Peter Hambsch et al. Oncotarget
- Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
- (2017) Janel Kydd et al. Pharmaceutics
- Selective cancer treatment via photodynamic sensitization of hypoxia-responsive drug delivery
- (2017) Hua He et al. Nanoscale
- Verteporfin inhibits growth of human glioma in vitro without light activation
- (2017) Ahmad Al-Moujahed et al. Scientific Reports
- Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
- (2016) Yang Liu et al. BIOMATERIALS
- Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer
- (2016) S. Percy Ivy et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
- (2016) Yang Zhao et al. JOURNAL OF CONTROLLED RELEASE
- A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways
- (2016) Bryan Q. Spring et al. Nature Nanotechnology
- Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
- (2016) Nicholas Brown et al. PLoS One
- The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review
- (2016) Yawei Wang et al. PLoS One
- Perfusion CT Estimates Photosensitizer Uptake and Biodistribution in a Rabbit Orthotopic Pancreatic Cancer Model
- (2015) Jonathan T. Elliott et al. ACADEMIC RADIOLOGY
- Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy
- (2015) Qian Chen et al. ACS Nano
- Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake
- (2015) Beatriz Pelaz et al. ACS Nano
- Topical antimicrobial photodynamic therapy improves angiogenesis in wounds of diabetic mice
- (2015) Khageswar Sahu et al. LASERS IN MEDICAL SCIENCE
- A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
- (2015) Elizabeth R. Gerstner et al. NEURO-ONCOLOGY
- PubChem Substance and Compound databases
- (2015) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- Prediction of Tumor Recurrence and Therapy Monitoring Using Ultrasound-Guided Photoacoustic Imaging
- (2015) Srivalleesha Mallidi et al. Theranostics
- CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer
- (2015) Jung-Min Lee et al. Frontiers in Oncology
- Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model
- (2015) Ramaswamy Bhuvaneswari et al. LASERS IN SURGERY AND MEDICINE
- Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma
- (2015) Merryl R. Lobo et al. PLoS One
- The Synergistic Biologic Activity of Oleanolic and Ursolic Acids in Complex with Hydroxypropyl-γ-Cyclodextrin
- (2014) Codruţa Soica et al. MOLECULES
- In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas
- (2014) Olga Martinho et al. Translational Oncology
- Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model
- (2013) Fahima Dilnawaz et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Retraction notice to ‘‘Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy’’ [Acta Biomaterialia 8 (2012) 2670–2687]
- (2012) Paromita Kundu et al. Acta Biomaterialia
- A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes
- (2012) Xiaoming Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells
- (2012) Md. Motarab Hossain et al. NEUROCHEMISTRY INTERNATIONAL
- Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape
- (2011) E. di Tomaso et al. CANCER RESEARCH
- Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles
- (2011) Marco P. Monopoli et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program
- (2011) Christopher L. Morton et al. PEDIATRIC BLOOD & CANCER
- Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivoin mice
- (2010) Zhiwei Hu et al. BMC CANCER
- Preparation of nanoparticles by solvent displacement for drug delivery: A shift in the “ouzo region” upon drug loading
- (2010) Moritz Beck-Broichsitter et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy
- (2010) Ramaswamy Bhuvaneswari et al. JOURNAL OF BIOMEDICAL OPTICS
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started